C4 Therapeutics, Inc. ( NASDAQ:CCCC – Get Rating ) was the recipient of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 2,920,000 shares, a decrease of 10.2% from the February 28th total of 3,250,000 shares. Currently, 7.2% of the company's stock are short sold. Based on an average daily volume of 571,400 shares, the short-interest ratio is presently 5.1 days. Analyst Upgrades and Downgrades Several equities analysts have recently weighed in on CCCC shares.

https://www.dailypolitical.com/2023/04/01/short-interest-in-c4-therapeutics-inc-nasdaqcccc-drops-by-10-2.html

#dailypolitical